Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years
Titel:
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years
Auteur:
Candoni, Anna Martinelli, Giovanni Toffoletti, Eleonora Chiarvesio, Alexia Tiribelli, Mario Malagola, Michele Piccaluga, Pier Paolo Michelutti, Angela Simeone, Erica Damiani, Daniela Russo, Domenico Fanin, Renato